New randomised control trial evidence for treatment of status epilepticus
Status epilepticus (SE) remains life thereatening condition with limited therepautic options. Benzodiazepine-refractory, or established, SE is thought to be of similar pathophysiology in children and adults, but differences in underlying aetiology and pharmacodynamics might differentially affect response to therapy (Chamberlain et al., 2020).
Read more here.
